Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
InMed Pharmaceuticals to Report Fourth Quarter, and Full Year Fiscal 2019 Financial Results and Business Update on September 19, 2019 | ||||||||||||||||||||
By: PR Newswire Association LLC. - 12 Sep 2019 | Back to overview list |
|||||||||||||||||||
TSX:IN VANCOUVER, Sept. 12, 2019 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade cannabinoids as well as a pipeline of medications targeting diseases with high unmet medical needs, will report financial results for the three and twelve months ended June 30, 2019, which is the Company's fourth quarter of fiscal year 2019 ("4Q19"), on Thursday, September 19, 2019. Conference Call & Webcast:
Replays, Available through September 26, 2019:
The Company's full financial statements and related MD&A for the three and twelve months ended June 30, 2019 will be available at www.sedar.com on September 19, 2019. About InMed: Cautionary Note Regarding Forward-Looking Information: All forward-looking information herein is qualified in its entirety by this cautionary statement, and InMed disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law. NEITHER THE TORONTO STOCK EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. View original content to download multimedia:http://www.prnewswire.com/news-releases/inmed-pharmaceuticals-to-report-fourth-quarter-and-full-year-fiscal-2019-financial-results-and-business-update-on-september-19-2019-300917170.html SOURCE InMed Pharmaceuticals Inc. |
||||||||||||||||||||
|
||||||||||||||||||||
Copyright 2019 PR Newswire Association LLC. | Back to overview list |